These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 18971882)

  • 21. A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.
    Tsukada H; Ochi H; Maekawa T; Abe H; Fujimoto Y; Tsuge M; Takahashi H; Kumada H; Kamatani N; Nakamura Y; Chayama K
    Gastroenterology; 2009 May; 136(5):1796-805.e6. PubMed ID: 19208361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virological and biochemical features in elderly HCV patients with hepatocellular carcinoma: amino acid substitutions in HCV core region as predictor of mortality after first treatment.
    Ogura S; Akuta N; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Kobayashi M; Suzuki F; Suzuki Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2009; 52(4):179-88. PubMed ID: 19546575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
    Hansen N; Obel N; Christensen PB; Krarup H; Laursen AL; Clausen MR; Lunding S; Møller A; Schlichting P; Kromann-Andersen H; Bukh J; Weis N;
    J Viral Hepat; 2009 Sep; 16(9):659-65. PubMed ID: 19486467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
    Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
    Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
    Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
    Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onset of Oral Lichen Planus Led to Direct-Acting Antiviral Therapy in a Patient with Long-Term Hepatitis C: The Role of a Dentist as Gatekeeper.
    Nagao Y; Tsuji M
    Case Rep Gastroenterol; 2023; 17(1):26-33. PubMed ID: 36742093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation Gap for Screening and Treatment of Hepatitis C Virus in Saga Prefecture, Japan: An Administrative Database Study of 35,625 Subjects.
    Isoda H; Oeda S; Takamori A; Sato K; Okada M; Iwane S; Takahashi H; Anzai K; Eguchi Y; Fujimoto K
    Intern Med; 2020 Jan; 59(2):169-174. PubMed ID: 31534084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effectiveness of a Liver Disease Education Class for Providing Information to Patients and Their Families.
    Kadokawa Y; Katayama K; Takahashi K; Fukushima N; Tanaka S; Taniguchi Y; Nawa T; Sakakibara M; Ohkawa K
    J Clin Med Res; 2017 Mar; 9(3):207-212. PubMed ID: 28179968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report.
    Misaka K; Kishimoto T; Kawahigashi Y; Sata M; Nagao Y
    Case Rep Gastroenterol; 2016; 10(3):617-622. PubMed ID: 27920651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects and outcomes of interferon treatment in Japanese hepatitis C patients.
    Yamasaki K; Tomohiro M; Nagao Y; Sata M; Shimoda T; Hirase K; Shirahama S
    BMC Gastroenterol; 2012 Oct; 12():139. PubMed ID: 23057417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the factors motivating HCV-infected patients to accept interferon therapy.
    Nagao Y; Sata M
    BMC Res Notes; 2012 Aug; 5():470. PubMed ID: 22932002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan.
    Nagao Y; Sata M
    Virol J; 2010 Dec; 7():375. PubMed ID: 21194423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of factors interfering with the acceptance of interferon therapy by HCV-infected patients.
    Nagao Y; Kawakami Y; Yoshiyama T; Sata M
    Med Sci Monit; 2008 Nov; 14(11):PI45-52. PubMed ID: 18971882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necessities of interferon therapy in elderly patients with chronic hepatitis C.
    Ikeda K; Arase Y; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
    Am J Med; 2009 May; 122(5):479-86. PubMed ID: 19375558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High incidence of multiple primary carcinomas in HCV-infected patients with oral squamous cell carcinoma.
    Nagao Y; Sata M
    Med Sci Monit; 2009 Sep; 15(9):CR453-9. PubMed ID: 19721396
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.